Search Tag: #DAPA-HF

Cardiology Management

#ESCCongress: DAPA-HF Trial - Reduction in Cardiovascular Death, Hospitalisation

2019 01 Sep

The DAPA-HF study findings were presented today by Dr. John McMurray at the ESC Congress in Paris.  DAPA-HF is an international, multi-centre, parallel-group, randomised, double-blind trial in patients with heart failure and reduced ejection fraction (LVEF = 40%), with and without type-2 diabetes, designed to evaluate the effect of dapagliflozin,... Read more